Meropenem Fresenius Kabi 500 mg inj./inf. sol. (pwdr.) i.v. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Meropenem Trihydrate 570 mg - Eq. Meropenem 500 mg

Available from:

Fresenius Kabi SA-NV

ATC code:

J01DH02

INN (International Name):

Meropenem Trihydrate

Dosage:

500 mg

Pharmaceutical form:

Powder for solution for injection/infusion

Composition:

Meropenem Trihydrate 570 mg

Administration route:

Intravenous use

Therapeutic area:

Meropenem

Product summary:

CTI code: 374087-01 - Pack size: 500 mg - Commercialisation status: NO - CNK code: 2834091 - Delivery mode: Medical prescription; CTI code: 374096-02 - Pack size: 10 x 500 mg - Commercialisation status: NO - CNK code: 2825420 - Delivery mode: Medical prescription; CTI code: 374096-01 - Pack size: 500 mg - Commercialisation status: NO - CNK code: 2834059 - Delivery mode: Medical prescription; CTI code: 374087-02 - Pack size: 10 x 500 mg - Commercialisation status: YES - FMD code: 05425025650767 - CNK code: 2825420 - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

2010-07-27